Market Overview:
The global urinary tract infection (UTI) testing market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market is segmented by type, application, and region. By type, the market is divided into kidney and bladder ultrasound UTI testing, cystoscopy UTI testing, and others. By application, the market is classified into hospitals, diagnostics laboratories, research institutes, and others. Geographically speaking North America dominates the global UTI testing market followed by Europe due to rising incidence of UTIs in these regions coupled with increasing demand for advanced diagnostic tests for better treatment outcomes.
Product Definition:
Urinary tract infection (UTI) testing is a series of tests that help to diagnose and treat urinary tract infections. UTI testing may include urine culture, urinalysis, and imaging studies. Urinary tract infection testing is important because it can help to identify the cause of the infection and guide treatment.
Kidney and Bladder Ultrasound Urinary Tract Infection Testing:
Kidney and bladder ultrasound urinary tract infection testing is used for the detection of bacteria in the urethra or urine. This test takes place during a physical examination of the urinary tract, it is also known as cystoscopy. The test involves sending high energy sound waves into body fluids to detect microorganisms such as bacteria, viruses or other parasites which are causing infections in urinary system.
Factors that propel growth factor in kidney.
Cystoscopy Urinary Tract Infection Testing:
The cystoscopy urinary tract infection (UTI) testing market is expected to witness lucrative growth over the forecast period owing to increasing prevalence of UTI and growing awareness about its treatment. According to a study published in NCBI, women are more prone towards developing UTIs than men. Cystoscopy is one of the most common diagnostic procedures for urinary tract infections (UTIs).
Application Insights:
Based on application, the global market is segmented into hospitals, diagnostics laboratories, research institutes and others. Hospitals are expected to be the major revenue contributor owing to their key role in providing diagnosis for UTI with sensitive and rapid detection methods. Diagnostic laboratories are also estimated to contribute significantly towards revenue generation as they offer highly accurate testing for various urinary tract infections (UTIs).
Research Institutes account for a smaller share of the overall market owing to high costs associated with them. However, these institutes play a significant role in discovering new treatment options and diagnostic tools for different types of UTIs which will eventually drive growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. High prevalence of urological disorders, rising government initiatives, and increasing healthcare expenditure are some of the major factors contributing to its growth. Moreover, technological advancements such as digital imaging and remote patient monitoring are further expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to high unmet clinical needs coupled with a large population base in this region. Furthermore, an increase in awareness regarding UTI diagnosis & treatment along with growing medical tourism industry will also boost revenue generation opportunities for key market players across this region during the forecast period from 2018 to 2030 or so far as it may concern oncology products in Japan and China that have been approved by regulatory authorities for commercialization since 2016 (Table 1).
Growth Factors:
- Increasing incidence of urinary tract infections (UTIs)
- Growing demand for point-of-care testing (POCT) devices
- Rising awareness about UTI diagnosis and treatment options
- Technological advancements in UTI testing methods and devices
- Growing number of private diagnostic laboratories
Scope Of The Report
Report Attributes
Report Details
Report Title
Urinary Tract Infection Testing Market Research Report
By Type
Kidney and Bladder Ultrasound Urinary Tract Infection Testing, Cystoscopy Urinary Tract Infection Testing, Others
By Application
Hospitals, Diagnostics Laboratories, Research Institutes, Others
By Companies
Roche, Stryker, Alere, Seimens, Sysmex, Cardinal Health, Arkray, Streck, Quidel, Danaher, Bio-Rad Laboratories, DIRUI, ACON Labs, URIT Medical Electronic, LabCorp, HOYA, Changchun Ruifa Investment
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
220
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Urinary Tract Infection Testing Market Report Segments:
The global Urinary Tract Infection Testing market is segmented on the basis of:
Types
Kidney and Bladder Ultrasound Urinary Tract Infection Testing, Cystoscopy Urinary Tract Infection Testing, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostics Laboratories, Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Stryker
- Alere
- Seimens
- Sysmex
- Cardinal Health
- Arkray
- Streck
- Quidel
- Danaher
- Bio-Rad Laboratories
- DIRUI
- ACON Labs
- URIT Medical Electronic
- LabCorp
- HOYA
- Changchun Ruifa Investment
Highlights of The Urinary Tract Infection Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Kidney and Bladder Ultrasound Urinary Tract Infection Testing
- Cystoscopy Urinary Tract Infection Testing
- Others
- By Application:
- Hospitals
- Diagnostics Laboratories
- Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Urinary Tract Infection Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Urinary tract infection (UTI) is a common problem that can be caused by bacteria, viruses, or fungi. A UTI may cause pain when urinating, a strong odor from the urine, and blood in the urine. If left untreated, a UTI can lead to more serious problems such as kidney failure.nnA doctor will usually test your urinary tract for signs of infection using a urine sample and an examination of the urinary tract. This may include checking for white blood cells (leukocytes) in the urine sample and looking for signs of inflammation or damage to the bladder or urethra.
Some of the key players operating in the urinary tract infection testing market are Roche, Stryker, Alere, Seimens, Sysmex, Cardinal Health, Arkray, Streck, Quidel, Danaher, Bio-Rad Laboratories, DIRUI, ACON Labs, URIT Medical Electronic, LabCorp, HOYA, Changchun Ruifa Investment.
The urinary tract infection testing market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Urinary Tract Infection Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Urinary Tract Infection Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Urinary Tract Infection Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Urinary Tract Infection Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Urinary Tract Infection Testing Market Size & Forecast, 2018-2028
4.5.1 Urinary Tract Infection Testing Market Size and Y-o-Y Growth
4.5.2 Urinary Tract Infection Testing Market Absolute $ Opportunity
Chapter 5 Global Urinary Tract Infection Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Urinary Tract Infection Testing Market Size Forecast by Type
5.2.1 Kidney and Bladder Ultrasound Urinary Tract Infection Testing
5.2.2 Cystoscopy Urinary Tract Infection Testing
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Urinary Tract Infection Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Urinary Tract Infection Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostics Laboratories
6.2.3 Research Institutes
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Urinary Tract Infection Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Urinary Tract Infection Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Urinary Tract Infection Testing Analysis and Forecast
9.1 Introduction
9.2 North America Urinary Tract Infection Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Urinary Tract Infection Testing Market Size Forecast by Type
9.6.1 Kidney and Bladder Ultrasound Urinary Tract Infection Testing
9.6.2 Cystoscopy Urinary Tract Infection Testing
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Urinary Tract Infection Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostics Laboratories
9.10.3 Research Institutes
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Urinary Tract Infection Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Urinary Tract Infection Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Urinary Tract Infection Testing Market Size Forecast by Type
10.6.1 Kidney and Bladder Ultrasound Urinary Tract Infection Testing
10.6.2 Cystoscopy Urinary Tract Infection Testing
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Urinary Tract Infection Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostics Laboratories
10.10.3 Research Institutes
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Urinary Tract Infection Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Urinary Tract Infection Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Urinary Tract Infection Testing Market Size Forecast by Type
11.6.1 Kidney and Bladder Ultrasound Urinary Tract Infection Testing
11.6.2 Cystoscopy Urinary Tract Infection Testing
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Urinary Tract Infection Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostics Laboratories
11.10.3 Research Institutes
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Urinary Tract Infection Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Urinary Tract Infection Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Urinary Tract Infection Testing Market Size Forecast by Type
12.6.1 Kidney and Bladder Ultrasound Urinary Tract Infection Testing
12.6.2 Cystoscopy Urinary Tract Infection Testing
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Urinary Tract Infection Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostics Laboratories
12.10.3 Research Institutes
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Urinary Tract Infection Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Urinary Tract Infection Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Urinary Tract Infection Testing Market Size Forecast by Type
13.6.1 Kidney and Bladder Ultrasound Urinary Tract Infection Testing
13.6.2 Cystoscopy Urinary Tract Infection Testing
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Urinary Tract Infection Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostics Laboratories
13.10.3 Research Institutes
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Urinary Tract Infection Testing Market: Competitive Dashboard
14.2 Global Urinary Tract Infection Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Stryker
14.3.3 Alere
14.3.4 Seimens
14.3.5 Sysmex
14.3.6 Cardinal Health
14.3.7 Arkray
14.3.8 Streck
14.3.9 Quidel
14.3.10 Danaher
14.3.11 Bio-Rad Laboratories
14.3.12 DIRUI
14.3.13 ACON Labs
14.3.14 URIT Medical Electronic
14.3.15 LabCorp
14.3.16 HOYA
14.3.17 Changchun Ruifa Investment
